GOLM1 UPREGULATES EXPRESSION OF PD-L1 THROUGH EGFR/STAT3 PATHWAY IN HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Yen, Jiuliang [1 ]
Zhou, Binghai [2 ]
Guo, Lei [1 ]
Zhang, Bo [1 ]
Liu, Shuang [3 ]
Zhang, Wentao [1 ]
Yu, Mincheng [1 ]
Chen, Zheng [1 ]
Xu, Yongfeng [1 ]
Xiao, Yongsheng [1 ]
Li, Hui [1 ]
Ye, Qinghai [4 ,5 ]
机构：
[1] Fudan Univ, Dept Liver Surg & Transplantat, Key Lab Carcinogenesis & Canc Invas, Liver Canc Inst,Zhongshan Hosp,Minist Educ, Shanghai 200032, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Nanchang 330006, Jiangxi, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Neurosurg, Shanghai 200032, Peoples R China
[4] Fudan Univ, Liver Canc Inst, Shanghai, Peoples R China
[5] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1095
引用
收藏
页码：664A / 664A
页数：1
相关论文
共 50 条
  • [1] GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma
    Yan, Jiuliang
    Zhou, Binghai
    Guo, Lei
    Chen, Zheng
    Zhang, Bo
    Liu, Shuang
    Zhang, Wentao
    Yu, Mincheng
    Xu, Yongfeng
    Xiao, Yongsheng
    Zhou, Jian
    Fan, Jia
    Li, Hui
    Ye, Qinghai
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (11): : 3705 - +
  • [2] HBV/HIV COINFECTION PROMOTES LIVER FIBROSIS PROGRESSION THROUGH A GOLM1/EGFR/STAT3/TGF-b1 PATHWAY
    Yan, Jiuliang
    Cheng, Zhimeng
    Huang, Peng
    Tian, Yanzhang
    Jeyarajan, Andre
    Shao, Tuo
    Duan, Xiaoqiong
    Guo, Lei
    Ye, Qinghai
    Lin, Wenyu
    Chung, Raymond T.
    HEPATOLOGY, 2020, 72 : 514A - 514A
  • [3] Expression of GOLM1 Correlates with Prognosis in Human Hepatocellular Carcinoma
    Ming-Huang Chen
    Yi-Hua Jan
    Peter Mu-Hsin Chang
    Yung-Jen Chuang
    Yi-Chen Yeh
    Hao-Jan Lei
    Michael Hsiao
    Shiu-Feng Huang
    Chi-Ying F. Huang
    Gar-Yang Chau
    Annals of Surgical Oncology, 2013, 20 : 616 - 624
  • [4] Expression of GOLM1 Correlates with Prognosis in Human Hepatocellular Carcinoma
    Chen, Ming-Huang
    Jan, Yi-Hua
    Chang, Peter Mu-Hsin
    Chuang, Yung-Jen
    Yeh, Yi-Chen
    Lei, Hao-Jan
    Hsiao, Michael
    Huang, Shiu-Feng
    Huang, Chi-Ying F.
    Chau, Gar-Yang
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S616 - S624
  • [5] Recent advances of GOLM1 in hepatocellular carcinoma
    Yan, Jiuliang
    Zhou, Binghai
    Li, Hui
    Guo, Lei
    Ye, Qinghai
    HEPATIC ONCOLOGY, 2020, 7 (02)
  • [6] PD-L1 expression in hepatocellular carcinoma
    Kanda, Hiroaki
    Mahmut, Yasin
    Shigematsu, Yasuyuki
    Sugiura, Yoshiya
    Yamamoto, Noriko
    Ishikawa, Yuichi
    CANCER SCIENCE, 2018, 109 : 1123 - 1123
  • [7] PD-L1 Expression Correlated with Clinicopathological Factors and Akt/Stat3 Pathway in Oral SCC
    Geum, Dong-Ho
    Hwang, Dae-Seok
    Lee, Chang-Hun
    Cho, Sung-Dae
    Jang, Min-A
    Ryu, Mi-Heon
    Kim, Uk-Kyu
    LIFE-BASEL, 2022, 12 (02):
  • [8] NME4 modulates PD-L1 expression via the STAT3 signaling pathway in squamous cell carcinoma
    Zheng, Shutao
    Liu, Qing
    Liu, Tao
    Yang, Lifei
    Zhang, Qiqi
    Shen, Tongxue
    Zhang, Xiao
    Han, Xiujuan
    Lu, Xiaomei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 526 (01) : 29 - 34
  • [9] microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3
    Li, Yaqin
    Zhou, Tao
    Cheng, Xianyi
    Li, Dezhi
    Zhao, Meng
    Zheng, Wei, V
    BIOENGINEERED, 2022, 13 (03) : 4730 - 4743
  • [10] GLIOBLASTOMA STAT3 AND PD-L1 EXPRESSION DRIVES ACCUMULATION OF IMMUNOSUPPRESSIVE LEUKOCYTES
    Kumar, Ravi
    Peterson, Timothy
    Parney, Ian
    NEURO-ONCOLOGY, 2014, 16
12345